IL-21 acts directly on B cells to regulate Bcl-6 expression and germinal center responses (original) (raw)

Abstract

During T cell–dependent responses, B cells can either differentiate extrafollicularly into short-lived plasma cells or enter follicles to form germinal centers (GCs). Interactions with T follicular helper (Tfh) cells are required for GC formation and for selection of somatically mutated GC B cells. Interleukin (IL)-21 has been reported to play a role in Tfh cell formation and in B cell growth, survival, and isotype switching. To date, it is unclear whether the effect of IL-21 on GC formation is predominantly a consequence of this cytokine acting directly on the Tfh cells or if IL-21 directly influences GC B cells. We show that IL-21 acts in a B cell–intrinsic fashion to control GC B cell formation. Mixed bone marrow chimeras identified a significant B cell–autonomous effect of IL-21 receptor (R) signaling throughout all stages of the GC response. IL-21 deficiency profoundly impaired affinity maturation and reduced the proportion of IgG1+ GC B cells but did not affect formation of early memory B cells. IL-21R was required on GC B cells for maximal expression of Bcl-6. In contrast to the requirement for IL-21 in the follicular response to sheep red blood cells, a purely extrafollicular antibody response to Salmonella dominated by IgG2a was intact in the absence of IL-21.

IL-21 belongs to a family of cytokines that bind the common cytokine receptor γ chain in conjunction with additional receptor subunits; IL-21 exclusively binds IL-21R (Spolski and Leonard, 2008). CD4+ T cells and NKT cells produce IL-21 (Parrish-Novak et al., 2000; Coquet et al., 2007). Within the CD4+ T cell subset, IL-21 is expressed at the highest levels by T follicular helper (Tfh) cells and Th17 cells (Chtanova et al., 2004; Nurieva et al., 2007; Bauquet et al., 2009). Its receptor is expressed on T cells, B cells, NK cells, macrophages, and DCs (Spolski and Leonard, 2008). IL-21 promotes antibody production, plasma cell differentiation, and switching to IgG1 in the context of thymus-dependent (TD) responses (Kasaian et al., 2002; Ozaki et al., 2002, 2004; Pène et al., 2004; Ettinger et al., 2005; Kuchen et al., 2007; Avery et al., 2008; Spolski and Leonard, 2008; Vogelzang et al., 2008). A requirement of IL-21 for Tfh cell differentiation has also been reported (Nurieva et al., 2008, 2009; Vogelzang et al., 2008); in naive T cells, IL-21 leads to up-regulation of Bcl-6, the transcriptional regulator of Tfh cells (Johnston et al., 2009; Nurieva et al., 2009; Yu et al., 2009). The defect in Tfh cell formation in the absence of IL-21 signaling has been proposed to explain the reduced numbers of germinal center (GC) B cells in the absence of IL-21 (Nurieva et al., 2008; Vogelzang et al., 2008).

After binding protein antigen and receiving cognate help from T cells, B cells can differentiate along the extrafollicular pathway, generating short-lived plasma cells that produce low affinity antibodies, or can enter the follicles and give rise to GCs (MacLennan et al., 2003). Within the GCs, B cells undergo somatic hypermutation, and those acquiring higher affinity for the immunizing antigen receive selection signals from Tfh cells. Selected cells emerge from the GCs as memory B cells or long-lived antibody-secreting plasma cells. Tfh and GC B cells have a mutual influence on each other: Tfh cells need B cell–derived signals for their optimal development (Nurieva et al., 2008) and Tfh cells are also essential for GC formation (Johnston et al., 2009; Nurieva et al., 2009; Yu et al., 2009). Nevertheless, normal GC induction with a paradoxical accumulation of IgG memory B cells was initially reported in Il21r−/− mice (Ettinger et al., 2008). We also recently reported that IL-21 deficiency did not reduce spontaneous GCs, Tfh cells, or autoimmunity in a lupus-prone mouse (Linterman et al., 2009b).

Given this evidence of the effects of IL-21 on B and T cells, we asked whether the reported effects of IL-21 on GCs may not only be secondary to the effects of IL-21 on Tfh cell formation but may also result from a direct influence on GC B cells. In this report, we show that IL-21 exerts direct effects on GC B cells, suggesting that the reduction of GC B cells is not only a consequence of reduced Tfh cells. Furthermore, we show that IL-21 is required for optimal affinity maturation and maximal expression of the GC B cell transcriptional regulator, Bcl-6.

RESULTS AND DISCUSSION

IL-21–deficient mice form reduced GCs that bind peanut agglutinin (PNA) weakly

To assess the role of IL-21 signaling in both GC and Tfh cell formation, we compared the responses of Il21+/+ and Il21−/− mice after TD immunization with sheep RBCs (SRBCs). Analysis of basal serum Igs revealed the reported reduction in serum IgG1 and elevated IgE titers in the absence of IL-21 (Fig. 1, A and B; Ozaki et al., 2002). The percentage of GC B cells identified by expression of GL-7 and Fas (CD95) was measured by flow cytometric analysis of splenocytes before or on days 6, 8, and 14 after immunization. Without immunization, IL-21–deficient mice have a reduction in the percentage of “background” GCs (P = 0.01). At day 6, there was a 40% reduction in the number of GC B cells in Il21−/− compared with Il21+/+ mice, reaching a 60% reduction by day 14 (P = 0.01; Fig. 1 C). These data demonstrate that IL-21 is not essential for initiating GC reactions but is required to reach GC peak numbers and maintain GC reactions.

Figure 1.

Figure 1.

IL-21–deficient mice form detectable GCs after immunization, but the kinetics of the GC is altered. (A and B) ELISA analysis of total serum IgG1 (A) and IgE (B) in unimmunized mice of the indicated genotypes. (C) Flow cytometric contour plots and graphical analysis of GL-7+Fas+ GC cells gated on live B220+ lymphocytes from Il21+/+ and Il21−/− mice at the indicated time points after SRBC immunization. Each symbol represents one mouse. (D) Photomicrographs of spleen sections stained for IgD (brown) and PNA (blue) from Il21+/+ and Il21−/− mice 8 d after immunization. Data are representative of two independent experiments (n ≥ 4 per group). Bars, 200 µm. (E) Flow cytometric histograms and graphical analysis of PNA binding on GL-7+Fas+B220+ GC B cells from Il21+/+ and Il21−/− mice 7 d after SRBC immunization. Statistically significant differences are indicated (*, P ≤ 0.05; **, P ≤ 0.01). Data are representative of two independent experiments, each symbol represents one mouse, and tops of bars are drawn through the median values. MFI, mean fluorescence intensity; ns, not significant.

To investigate whether GCs were forming in secondary follicles, spleen sections were stained for follicular mantle B cells (IgD, brown) and GC B cells (PNA, blue; Fig. 1 D). We observed PNA+ GCs in both Il21+/+ and Il21−/− mice, although the intensity of PNA staining appeared to be reduced in IL-21–deficient mice and the GCs had a slightly altered morphology (Fig. 1 D and Fig. S1 A). The mean fluorescence intensity of PNA binding was approximately twofold lower on GC cells derived from Il21−/− mice compared with Il21+/+ controls (P = 0.03; Fig. 1 E). PNA is a lectin that binds nonsialylated core 1 O-glycans. The sialyltransferase ST3Gal I adds sialic acid to the core 1 O-glycans, producing a structure not recognized by PNA (Priatel et al., 2000). Quantitative RT-PCR on sorted GC B cells from SRBC-immunized Il21+/+ and Il21−/− mice did not reveal statistically significant increases in the amount of ST3Gal and ST6Gal mRNA expression between both groups of mice (Fig. S1 B), suggesting that changes in these two enzymes are not responsible for reduced PNA binding in the absence of IL-21.

Tfh cells form but decline faster in the absence of IL-21

We investigated the kinetics of Tfh cell formation after SRBC immunization in IL-21–deficient mice by enumerating CXCR5highPD-1high CD4+ Tfh cells by flow cytometry on days 0, 6, 8, and 14 after SRBC immunization. In the absence of immunization, there were fewer background Tfh cells in Il21−/− compared with Il21+/+ mice (Fig. 2 A). We observed normal generation of Tfh cells in Il21−/− mice, with equivalent proportions on day 6 after immunization compared with Il21+/+ mice (Fig. 2 A). Although formation was normal, there was a more rapid decline in Tfh cell numbers in Il21−/− mice (Fig. 2 A). There was a slight decrease in the total number of CD4+ cells in the absence of IL-21 (Fig. S1 C), although this was not statistically significant.

Figure 2.

Figure 2.

IL-21–deficient mice form Tfh cells after immunization, but their maintenance is impaired. (A) Flow cytometric contour plots and graphical analysis of CXCR5+PD-1+ Tfh cells gated on CD4+ B220− live lymphocytes from Il21+/+ and Il21−/− mice at the indicated time points after SRBC immunization (percentages are shown). (B) Photomicrographs of spleen sections taken from Il21+/+ (top) and Il21−/− (bottom) mice 8 d after immunization with SRBCs. In all panels, IgD is stained in brown; blue color stains indicate PNA binding (left), CD3 (middle), and PD-1 (right). Bars, 200 µm. Statistically significant differences are indicated (*, P ≤ 0.05). Data are representative of two independent experiments, each symbol represents one mouse, and tops of bars are drawn through the median values. ns, not significant.

T cells could be easily identified in the GCs of IL-21–deficient mice 8 d after immunization (Fig. 2 B). In the absence of IL-21, there were more T cells per 1 mm2 of GC area than in IL-21–sufficient mice (166 vs. 104 CD3+ cells/mm2, respectively; P = 0.03), and on average there were slightly more T cells per GC in Il21−/− compared with Il21+/+ mice (22 ± 15 vs. 16 ± 14, respectively; P = 0.2). Despite this increase in the number of follicular T cells per GC, the total number of T cells found in follicles per square millimeter of spleen area was reduced in IL-21–deficient mice (97 ± 44 vs. 126 ± 34 per section; P = 0.05), consistent with the results obtained by flow cytometric staining on day 8. This is explained by the smaller size of GCs in IL-21–deficient mice. Collectively, these data indicate that IL-21 is not required for Tfh cell formation but contributes to Tfh cell maintenance.

We also investigated the possibility that GC B cell and/or Tfh cell proliferation might be reduced in the absence of IL-21. Enumeration of Ki-67+ cells among CD4+CXCR5+PD-1+ Tfh cells did not reveal any differences in mice deficient for IL-21 (Fig. S2 A). Likewise, there was no difference in the proportion of Ki-67+ cells among B220+GL-7+Fas+ GC cells in the absence of IL-21 (Fig. S2 B).

IL-21R signals in B cells are required for GC formation and maintenance

To investigate whether IL-21R signaling in the B cells themselves is required for GC formation, we generated Il21r+/+/Il21r−/− mixed bone marrow chimeras. Sublethally irradiated Rag1−/− mice were reconstituted with a 1:1 mix of either CD45.1 Il21r+/+/CD45.2 Il21r+/+ or CD45.1 Il21r+/+/CD45.2 Il21r−/− bone marrow. 8 wk later, chimeric mice were immunized with SRBCs and the percentage of B220+ cells, GL-7+Fas+B220+ GC B cells, CD4+ T cells, and CXCR5highPD-1high CD4+ Tfh cells derived from the CD45.2 (Il21r−/− or control Il21r+/+) donor marrow in each mouse was determined (Fig. 3, A and B; and Fig. S3).

Figure 3.

Figure 3.

IL-21R expression is required on both GC B cells and Tfh cells for their maintenance but is dispensable for their formation. (A and B) Gating strategy (A) and bar graphs (B) of mixed bone marrow chimeras containing a 1:1 ratio of control _Il21r+/+_CD45.1/_Il21r+/+_CD45.2 or _Il21r+/+_CD45.1/_Il21r−/−_CD45.2 bone marrow. Spleens from unimmunized mice (A; and B, top) or from mice immunized with SRBCs 6 or 14 d previously (B, middle and bottom) were analyzed by flow cytometry for the percentage of B220+ B cells that are CD45.2+ (B220+), the percentage of GL-7+Fas+ GC cells among B220+ cells that are CD45.2+ (GC cells), the percentage of CD4+ Th cells that are CD45.2+ (CD4+), and the percentage of CXCR5highPD-1high Tfh cells among CD4+ cells that are CD45.2+ (Tfh cells). Each bar represents a single recipient mouse; individual mice have been numbered and placed in the same order in each of the plots. Statistically significant decreases are indicated (*, P ≤ 0.05; **, P ≤ 0.01; ***, P ≤ 0.001). Data are representative of two independent experiments. (C and D) Gating strategy (C) and dot plots (D) of the proportion of B220+, GC (B220+Fas+GL-7+), and IgG1+ GC (B220+Fas+GL-7+IgG1+) cells derived from the CD45.2 compartment of mixed chimeras reconstituted with a 1:1 ratio of either CD45.1 Il21r+/+/CD45.2 Il21r+/+ (left) or CD45.1 Il21r+/+/CD45.2 Il21r−/− (right) bone marrow before (C; and D, top) or 6 d after SRBC immunization (D, bottom). In D, each number represents a single recipient mouse from two separate groups of the chimeric mice indicated above the left and right panels.

In unimmunized mice, in which 50% of total B220+ cells were of CD45.2 Il21r−/− origin (P = 0.003), there was a median 60% reduction (P < 0.01) in background GC cells derived from CD45.2 Il21r−/− marrow. In control chimeras, the percentage of CD45.2 GC cells derived from Il21r+/+ bone marrow (45%) was comparable to the proportion of CD45.2 cells among total B220+ cells (Fig. 3 B, top left; and Fig. S3). On day 6 after immunization, the proportion of CD45.2 GC cells was also significantly lower (41% decrease; P < 0.001) than the rate of reconstitution of CD45.2 B220+ B cells in recipients of CD45.1 Il21r+/+/CD45.2 Il21r−/− bone marrow (Fig. 3 B, middle left). A statistically significant 36% (P < 0.01) reduction in CD45.2 GC B cells derived from Il21r−/− marrow was also seen 14 d after immunization (P = 0.03; Fig. 3 B, bottom left; and Fig. S3). We also observed statistically significant reductions in the percentage of Tfh cells derived from CD45.2 Il21r−/− bone marrow compared with control CD45.1 Il21r+/+/CD45.2 Il21r+/+ chimeras at the time points examined (Fig. 3, A and B, right; and Fig. S3). These reductions were smaller than the effects observed in GC B cells. Collectively, these results suggest that IL-21 acts directly on B cells to form and maintain GCs and exerts modest but also cell-intrinsic effects on Tfh cells.

Previous reports have shown a more profound effect of IL-21 on GC and Tfh cell formation than those shown in this report. The function of common γ chain cytokines is modified by the context in which they are delivered (Rochman et al., 2009), and there is evidence suggesting that the magnitude of Tfh cell populations is influenced by the types of antigen, adjuvant, and avidity of TCR (Ansel et al., 1999; Malherbe et al., 2008; Fazilleau et al., 2009). It is therefore likely that weaker immunization strategies, e.g., smaller doses of SRBCs or cells with decreased immunogenicity (i.e., less fresh), may increase the dependence on IL-21 and may induce a faster decline in GC and Tfh cells. It is also possible that the differences reported in this paper are caused by the genetic background of the mice used. Former studies used Il21−/− mice either on a mixed 129xB6 F1 background or on a 129xB6 background backcrossed seven generations to B6. The mice used in this study were also generated on the 129xB6 background and backcrossed 10–12 generations to B6, and as such, would be expected to have a maximum of 0.1% 129 genome. IL-2 plays an essential role in T cell expansion and is tightly linked to the IL-21 locus. Our analysis of polymorphic markers between 129 and C57BL/6 revealed that the IL-2 locus is also derived from the 129 background in our N10 backcrossed mice (unpublished data), excluding this as a modifier of the Tfh cell phenotype in this study. Given the described ability of IL-6 to induce Bcl-6 (Nurieva et al., 2009), the modest effect of IL-21R signaling on Tfh cell formation is also probably explained by functional redundancy between IL-21 and IL-6. As has been described for Th17 cell formation, it is possible that a role for IL-21 would become more apparent in IL-6–deficient mice (Korn et al., 2007; Nurieva et al., 2007; Zhou et al., 2007; Coquet et al., 2008; Sonderegger et al., 2008). Furthermore, other cytokines may also contribute to Tfh cell formation. In humans, IL-12 can induce human T cells to differentiate into IL-21–producing Tfh-like cells in vitro (Schmitt et al., 2009).

Given the reports of reduced IgG1 responses in immunized IL-21–deficient mice (Ozaki et al., 2002), we investigated whether the decline in GC B cells was mainly caused by loss of IgG1+ GC B cells. After SRBC immunization, ∼20% of GC B cells within the CD45.2 Il21r+/+ compartment are IgG1+. This proportion was only slightly reduced among the Il21r−/− GC cells (17%; unpublished data). However, analysis of the proportion of GC B cells and IgG1+ GC B cells of CD45.2 origin in each chimera revealed a parallel decline in IL-21R–deficient GC B cells and IgG1+ GC B cells 6 d after SRBC immunization (Fig. 3, C and D). IgG1+ IL-21R–deficient GC B cells were virtually absent in unimmunized mice. This suggests that IL-21 deficiency profoundly, but not exclusively, affects Ig switching to IgG1 and/or maintenance of IgG1+ GC B cells.

IL-21 is required for optimal affinity maturation but not for early memory (EM) B cell formation

To investigate how IL-21 affects the process of affinity maturation and formation of EM B cells, CD45.1 SWHEL transgenic B cells bearing a rearranged hen egg lysozyme (HEL)–specific VDJH element targeted into the H chain locus combined with an HEL-specific κ L chain transgene (Phan et al., 2003) were adoptively transferred into IL-21–deficient or –sufficient CD45.2 recipients. The recipients were then immunized with SRBCs conjugated with HEL protein bearing three substitutions (HEL3X), which binds the Ig receptors on SWHEL B cells with substantially lower affinity compared with native HEL, enabling affinity maturation to proceed normally (Phan et al., 2003; Paus et al., 2006). Flow cytometric staining with nanomolar concentrations of HEL3X can directly enumerate high affinity IgG+ variants (Phan et al., 2003; Paus et al., 2006); quantification of the proportion of HEL3Xhi-binding B cells by flow cytometry closely reflects the acquisition of mutations that confer higher affinity for the immunizing HEL3X (Phan et al., 2003; Paus et al., 2006; Randall et al., 2009). In HEL3X SRBC–immunized IL-21–deficient recipients, there was a 72% reduction in HEL3Xhi-binding GC B cells (P = 0.035) 10 d after immunization compared with IL-21–sufficient recipients (Fig. 4, A and B). This shows that IL-21 is required for optimal affinity maturation.

Figure 4.

Figure 4.

IL-21 contributes to affinity maturation but is dispensable for EM B cell formation. (A) Representative flow cytometric contour plots of donor CD45.1 SWHEL cells from the spleens of Il21+/+ or Il21−/− recipient mice 10 d after adoptive transfer and immunization with HEL3X SRBCs. Contour plots show IgG1+ cells binding with high (top oval gates) and low (bottom oval gates) affinity to HEL3X (percentages are shown). (B) Bar graphs show HEL3X hi IgG1+ CD45.1 cells (top oval gates in A) as a proportion of all HEL3X-binding IgG1+ cells (square gates in A). This figure is representative of two independent experiments (n ≥ 3 mice per group. (C) Ratio of total Tfh (CXCR5highPD-1high CD4+) cells to total HEL-binding donor (CD45.1) GC B cells (Fas+GL-7+). Two independent experiments are represented in this plot. (D) Representative flow cytometric contour plots 10 d after adoptive transfer of SWHEL B cells into Il21+/+ or Il21−/− mice and immunization with HEL3X SRBCs gated on donor CD45.1 and HEL-binding cells (percentages are shown). The gates show GC cells (HELint binding) and EM B cells (HELhi binding). (E) Phenotype of GC B cells and EM cells gated as in D. (F and G) Total number of donor HELint-binding GC B cells per spleen (F) and the proportion of donor HELhi-binding EM B cells (G) in mice of the indicated genotypes gated as in D. Each symbol represents one mouse and tops of bars are drawn through the median values. Statistically significant differences are indicated (**, P ≤ 0.01).

We also observed a higher ratio of Tfh cells to HEL-binding donor derived GC B cells (Fig. 4 C). This is in line with our earlier observation of smaller GCs and an increased number of Tfh cells per GC. It has been speculated that reduced competition for Tfh cells may lower the stringency of the selection process (Allen et al., 2007).

Memory B cells can form independently of the GC response (Blink et al., 2005; Inamine et al., 2005; Chan et al., 2009). After adoptive transfer of SWHEL B cells and HEL3X SRBC immunization, donor-derived EM B cells can be identified on the basis of their B220high BCRhigh phenotype; these cells express low levels of GL-7 and Fas, and high levels of CD38 (Chan et al., 2009). Most of these EM B cells have been reported to be unswitched and of low affinity, and have undergone limited division, suggesting that they have left the response before GC formation (Chan et al., 2009). We investigated the dependence of these memory cells on IL-21. Although GC B cells (BCRint) were reduced both in total numbers and as a proportion of HEL-binding donor cells in the spleens of IL-21–deficient recipients, the proportion of EM B cells (BCRhi) out of all HEL-binding donor cells remained comparable (P = 0.786; Fig. 4, D–G), as did total EM B cell numbers (not depicted).

IL-21 acts directly in B cells to regulate Bcl-6 expression in GC cells

Bcl-6 is essential for the generation of the GC response (Dent et al., 1997). We have recently shown that Bcl-6 acts in a gene dose–dependent manner: halving the gene dose of Bcl-6 reduced GCs after SRBC immunization by nearly 50% (Linterman et al., 2009b). In addition, previous work has demonstrated that unmutated memory B cells can form in the absence of Bcl-6 (Toyama et al., 2002) and that IL-21 induces Bcl-6 expression in CD4+ T cells (Nurieva et al., 2009). Thus, we speculated that the mechanism by which IL-21 contributes to GC formation and affinity maturation might be through induction or maintenance of Bcl-6 in GC B cells.

To test this hypothesis, we quantified Bcl-6 protein levels by flow cytometry in mixed CD45.1 Il21r+/+/CD45.2 Il21r−/− chimeric mice 6 d after SRBC immunization. As expected, Bcl-6 was up-regulated in GC B cells compared with non-GC B cells (Fig. 5, A and B). Strikingly, in every mouse analyzed, GC B cells lacking IL-21R expression showed a significant reduction (P = 0.002) in Bcl-6 levels compared with Il21r+/+ GC B cells in the same mouse (Fig. 5, B and C). This suggests that IL-21 contributes to GC B cell formation by signaling directly in B cells to induce maximal expression of Bcl-6. There are multiple ways by which Bcl-6 defects may impair affinity maturation: by decreasing the efficiency of somatic hypermutation through direct or indirect effects on AID expression; by promoting early differentiation and exit of GC B cells from the GCs, preventing them from undergoing successive rounds of mutation; or by reducing the ability of GC B cells to interact and elicit survival signals from follicular DCs or Tfh cells.

Figure 5.

Figure 5.

Lack of IL-21R signaling reduces the expression of Bcl-6 in GC B cells. (A) Flow cytometric contour plots indicating the gating strategy for non-GC and GC B220+ cells (left) and BCL-6 expression on GL-7+ (middle) and Fas+ (right) B cells. (B and C) Histogram overlays (B) and bar graphs (C) showing the fluorescence intensity of BCL-6 staining in GC and non-GC B cells as gated in A derived from the CD45.1 Il21r+/+ or CD45.2 Il21−/− compartment of CD45.1 Il21r+/+/CD45.2 Il21r−/− mixed bone marrow chimeras 6 d after SRBC immunization. The horizontal dashed line highlights the median levels of Bcl-6 found in non-GC B cells. Each set of two bars represents the data from the CD45.1 and CD45.2 compartments of a single mouse. MFI, mean fluorescence intensity.

IL-21 is not required for pathogen clearance or extrafollicular humoral immunity after Salmonella infection

Previous reports have revealed that IL-21 can support plasma cell differentiation from naive B cells in vitro (Ettinger et al., 2007). In vivo, large numbers of BLIMP-1+ plasma cells are found in IL-21 transgenic mice (Ozaki et al., 2004), but this study could not differentiate whether the plasma cells were of follicular (GC) or extrafollicular origin. IL-21–producing T cells have been reported to colocalize with extrafollicular plasma cell foci in the autoimmune lpr mouse strain (Odegard et al., 2008). To investigate whether IL-21 is required for an extrafollicular response against an infectious pathogen, we chose Salmonella infection as a model. The initial humoral response to Salmonella species infection requires CD4+ T cell help, and the early phase of the antibody response is derived purely from extrafollicular plasma cells; GCs do not form until at least 5 wk after infection (Hess et al., 1996; Yrlid and Wick, 2000; Cunningham et al., 2007). Il21+/+ and Il21−/− mice were infected with live attenuated Salmonella enterica serovar Dublin strain SL5631, which also elicits a CD28-dependent antibody response derived exclusively from extrafollicular foci and dominated by IgG2ab production (Linterman et al., 2009a). Consistent with previous reports, GC responses were absent 12 d after Salmonella infection (Fig. S4). There was no difference in the amount of _Salmonella_-specific IgM, IgG2ab, IgG2b, or IgG3 between Il21+/+ and Il21−/− mice (Fig. 6 A). Bacterial clearance was also intact in the absence of IL-21 (Fig. 6, B and C). These data demonstrate that normal extrafollicular antibody responses can be achieved in the absence of IL-21.

Figure 6.

Figure 6.

Lack of IL-21 does not alter Salmonella pathogen clearance or production of anti-Salmonella humoral immunity. (A) ELISA analysis of the titers of _Salmonella_-specific IgM, IgG1, IgG2ab, IgG2b, and IgG3 in sera from Il21+/+(white bars) and Il21−/− (black bars) mice 12 d after Salmonella infection. (B and C) Dot plots of spleen weights (B) and the number of bacteria per liver (C) in Il21+/+ and Il21−/− mice 12 d after infection with Salmonella. Data are representative of two independent experiments. Each symbol represents one mouse and tops of bars are drawn through the median values. nd, not detected.

Evaluation of antibody responses to other Th1 pathogens such as Toxoplasma gondii have shown reduced antibody titers at day 100 after infection in Il21r−/− mice (Ozaki et al., 2002). These antibodies most likely derive from GCs, given that extrafollicular plasma cells are short lived and the half-life of IgGs is <3 wk. Also, in contrast to the response to Salmonella, both extrafollicular foci and GCs with proliferating centroblasts can be observed during T. gondii infection (Rifaat et al., 1981). After immunization with ovalbumin or KLH, antigen-specific IgG1 levels in Il21r−/− mice were lower than wild type, and antigen-specific IgE was produced at much higher titers (Ozaki et al., 2002). In addition, there was a specific reduction in IgG1+ plasma cells (Ettinger et al., 2008). Collectively, this evidence suggests that IL-21 is dispensable for non-IgG1 extrafollicular antibody but it is still possible that IL-21 is required for IgG1+ extrafollicular responses.

This report provides further evidence of the complex biological functions of IL-21 in immune responses, demonstrating direct effects on GC B cells that regulate GC initiation, long-term maintenance, production of GC IgG1+ B cells, and affinity maturation. Our data underscore the accumulating evidence of shared signaling pathways in T and B cells to regulate follicular responses: in both GC and Tfh cells, IL-21 regulates expression of the transcriptional regulator that directs their lineage commitment, Bcl-6. The data presented in this paper have implications for immunotherapy: dampening IL-21 signaling may be useful to diminish production of high affinity autoantibodies, and IL-21 may be useful in vaccine development for its ability to promote long-lived and high affinity–matured antibody responses.

MATERIALS AND METHODS

Mice and immunizations.

C57BL/6 (B6) and Il21−/− mice were housed in specific pathogen-free conditions at the Australian National University (ANU) Bioscience Facility. Il21r−/− mice were housed under specific pathogen-free conditions at the Peter MacCallum Cancer Center. Il21−/− mice were generated at Lexicon Genetics (now Lexicon Pharmaceuticals) and provided by ZymoGenetics, Inc. These mice were backcrossed 12 generations onto the C57BL/6 background. Primers used to amplify polymorphisms that distinguish between the 129 and C57BL/6 genetic backgrounds of the interval comprising the Il2 gene in Il21−/− mice were provided by C. King (Garvan Institute of Medical Research, Sydney, Australia). Il21r−/− mice were provided by W. Leonard (National Institutes of Health, Bethesda, MD) and were backcrossed 12 generations onto the C57BL/6 background. SWHEL mice carry a Vk10 κ L chain transgene and a knocked-in VH10 H chain in place of the JH segments of the endogenous IgH gene that encodes a high affinity antibody for HEL (Phan et al., 2003). All animal procedures were approved by the ANU Animal Ethics and Experimentation Committee. To generate TD GC responses, 8–12-wk-old mice were immunized intraperitoneally with 2 × 109 SRBCs (IMVS Veterinary Services).

Adoptive transfer of SWHEL splenocytes.

105 CD45.1 SWHEL B cells and 2 × 108 SRBCs (IMVS Veterinary Services) conjugated to low affinity HEL3X antigen were adoptively transferred into Il21+/+ or Il21−/− (CD45.2) mice via intravenous injection, as described previously (Paus et al., 2006).

Bacteria and inoculation.

S. enterica serovar Dublin strain SL5631 (Segall and Lindberg, 1991) was grown in Luria-Bertani medium overnight. Mice were inoculated with 5 × 105 CFUs from a log-phase culture administered intraperitoneally in PBS. Liver bacterial load was measured at day 12 after infection by homogenizing organs, plating serial dilutions in PBS onto Luria-Bertani agar, and incubating at 37°C overnight.

Antibodies.

Antibodies and streptavidin conjugates for flow cytometry were from BD except where otherwise indicated: anti–mouse B220-PerCP, CD4-PerCP, inducible T cell co-stimulator–FITC (eBioscience), GL-7–FITC, Fas-PE, CXCR5-biotin, PD-1–PE (eBioscience), PNA-biotin (Vector Laboratories) CD8-allophycocyanin (APC), streptavidin–PerCP-Cy5.5, streptavidin–PE-Cy7, CD38-PE, CD45.2–PerCP-Cy5.5, IgG1-PE, Ki-67–A647, HyHEL9–Alexa Fluor 647, B220–APC-Cy7, CD45.1–Pacific blue, Ki-67–Alexa Fluor 647, and Bcl-6 (Santa Cruz Biotechnology, Inc.) conjugated to Alexa Fluor 647 using an antibody conjugation kit (Invitrogen). For immunohistochemistry, the primary antibodies and reagents used were sheep anti–mouse IgD (The Binding Site), biotinylated anti–mouse CD3 (BD), and PNA-biotin (Vector Laboratories); the secondary antibodies used were rat anti–goat IgG and streptavidin–alkaline phosphatase (Vector laboratories); and the tertiary antibody used was rabbit anti–rat horseradish peroxidase (HRP; Dako).

Bone marrow chimeras.

Recipient C57BL/6-CD45.1 Rag1_−/−_ mice were sublethally irradiated with 1,000 rad and reconstituted via intravenous injection with 2 × 106 donor bone marrow–derived hematopoietic stem cells.

Cell isolation, culture, and stimulation.

Single-cell suspensions were prepared from spleens of immunized mice by sieving and gentle pipetting through 70-µm nylon mesh filters (Falcon; BD). Splenocytes were suspended in RPMI 1640 medium (JRH Biosciences) supplemented with 2 mM l-glutamine (Invitrogen), 100 U penicillin-streptomycin (Invitrogen), 0.1 mM of nonessential amino acids (Invitrogen), 100 mM Hepes (Sigma-Aldrich), 5 × 105 2-mercaptoethanol, and 10% FCS.

Flow cytometry.

For surface staining, single-cell suspensions were prepared as described in the previous section, and cells were maintained in the dark at 4°C throughout the experiment. Cells were washed twice in ice-cold FACS buffer (2% FCS, 0.1% NaN3 in PBS), and incubated with each antibody and conjugate layer for 30 min and washed thoroughly with FACS buffer between each layer. Intracellular staining used the Cytofix/Cytoperm kit (BD) according to the manufacturer’s instructions. For detection of Bcl-6 expression and HEL-binding B cells, HyHEL9 and rabbit polyclonal anti–Bcl-6 were conjugated to Alexa Fluor 647 (Invitrogen) using an antibody labeling kit (Invitrogen). Flow cytometers (FACSCalibur and LSR II; BD) and software (CellQuest or FACSDiva, respectively; BD) were used for the acquisition of flow cytometric data, and FlowJo software (Tree Star, Inc.) was used for analysis.

ELISA.

Anti-Salmonella IgM, IgG1, IgG2ab, IgG2b, and IgG3 (SouthernBiotech) were detected in plasma from blood taken at days 7 and 12 by ELISA. 96-well ELISA plates (Thermo Fisher Scientific) were coated with SL5631 cell lysate. The lysate was prepared from an overnight culture using a French press. Protein concentration in the lysate was determined by Bradford assay and each well was coated with 12.5 µg of protein.

For analysis of total IgG, IgG1, and IgE titers, MaxiSorp plates (Thermo Fisher Scientific) were coated with goat anti–mouse κ L chain or anti–mouse IgE (BD). Serial serum dilutions were applied and Ig concentration was determined with HRP-conjugated goat anti–mouse IgG, IgG1 (SouthernBiotech), or biotinylated IgE (BD), followed by streptavidin-HRP. The enzyme bound to plates was developed using phosphatase substrate tablets (Sigma-Aldrich). Plates were read at 405 nm using a Thermomax Microplate Reader (MDS Analytical Technologies). The titers for serum samples were calculated as the log serum concentration required to achieve 50% maximum OD.

Immunohistochemistry.

5-µm acetone-fixed frozen sections of spleen were air dried and washed in 0.1 M Tris-buffered saline (TBS), pH 7.6, and stained with various antibodies for 45 min at room temperature in a moist chamber. After a further wash in TBS, secondary reagents, previously absorbed in 10% normal mouse serum, were added to the sections for 45 min. Where biotin-conjugated primary or secondary reagents were used, streptavidin–alkaline phosphatase was added after a further wash in TBS and incubated for 20 min. HRP activity was detected using diaminobenzidine tetrahydrochloride solution (Sigma-Aldrich) and hydrogen peroxide. Alkaline phosphatase activity was detected using the Alkaline Phosphatase Substrate Kit III (Vector Laboratories). Sections were mounted with IMMU-MOUNT (Thermo Fisher Scientific) and viewed under a microscope (IX71; Olympus).

Real-time PCR analysis.

GC B cells were induced with an intraperitoneal injection of SRBCs (as described in Mice and immunizations), and GL-7+Fas+B220+ GC cells were sorted using a FACSAria (BD). RNA was extracted using an RNeasy kit (QIAGEN) according to the manufacturer’s instructions, and cDNA was produced from 500 ng RNA using SuperScript III (Invitrogen) according to the manufacturer’s instructions. Primers specific for ST3Gal I, ST6Gal I, and the housekeeping gene β-actin (ST3Gal I forward, 5′-ACAGGCACCATCACTCACAC-3′; ST3Gal I reverse, 5′-GATGAAGGCTGGGTGGTAGA-3′; ST6Gal I forward, 5′-TCAACCTCAAGAAGTGGAGTTTC-3′; ST6Gal I reverse, 5′-TGATCACACACTGGTTGCAC-3′; β-actin forward, 5′-CAGCCATGTACGTTGCTATC-3′; β-actin reverse, 5′-AAGGAAGGCTGGAAGAGTG-3′) were used to amplify the cDNA, in the presence of SYBR green, on a real-time PCR system (model 7900; Applied Biosystems). The gene-specific fold change, normalized to β-actin, was calculated using the 2−ΔΔct method.

Statistical analysis.

All data were analyzed using the nonparametric Mann-Whitney U test, excluding bone marrow chimera experiments in Fig. 3 and Fig. 5, which were analyzed using a paired Student’s t test. All statistical analyses were performed with Prism software (version 5; GraphPad Software, Inc.).

Online supplemental material.

Fig. S1 shows photomicrographs of spleen sections from Il21−/− or Il21+/+ mice after SRBC immunization stained with IgD and PNA, and compares expression levels of ST3Gal I and ST6Gal I from GC cells in immunized Il21−/− or Il21+/+ mice and the total number of CD4+ cells in the same mice. Fig. S2 depicts the proportion of Tfh and GC cells that express Ki67 from Il21+/+ and Il21−/− mice after immunization. Fig. S3 presents an alternative way of analyzing the bone marrow chimera data from Fig. 3. Fig. S4 shows the proportion of B cells that have a GC phenotype 12 d after infecting Il21+/+ and Il21−/− mice with Salmonella. Online supplemental material is available at http://www.jem.org/cgi/content/full/jem.20091738/DC1.

Acknowledgments

We thank C. King for primers to detect 129 versus C57BL/6 polymorphisms, and R. Brink for help and advice with experiments using SWHEL mice.

C.G. Vinuesa is supported by a Viertel Senior Medical Research Fellowship. This work was funded by a National Health and Medical Research Council program grant to C.G. Vinuesa.

The authors have no conflicting financial interests.

Footnotes

Abbreviations used:

EM

early memory

GC

germinal center

HEL

hen egg lysozyme

PNA

peanut agglutinin

SRBC

sheep RBC

TD

thymus dependent

Tfh

T follicular helper

References

  1. Allen C.D., Okada T., Cyster J.G. 2007. Germinal-center organization and cellular dynamics. Immunity. 27:190–202 10.1016/j.immuni.2007.07.009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Ansel K.M., McHeyzer-Williams L.J., Ngo V.N., McHeyzer-Williams M.G., Cyster J.G. 1999. In vivo–activated CD4 T cells upregulate CXC chemokine receptor 5 and reprogram their response to lymphoid chemokines. J. Exp. Med. 190:1123–1134 10.1084/jem.190.8.1123 [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Avery D.T., Bryant V.L., Ma C.S., de Waal Malefyt R., Tangye S.G. 2008. IL-21-induced isotype switching to IgG and IgA by human naive B cells is differentially regulated by IL-4. J. Immunol. 181:1767–1779 [DOI] [PubMed] [Google Scholar]
  4. Bauquet A.T., Jin H., Paterson A.M., Mitsdoerffer M., Ho I.C., Sharpe A.H., Kuchroo V.K. 2009. The costimulatory molecule ICOS regulates the expression of c-Maf and IL-21 in the development of follicular T helper cells and TH-17 cells. Nat. Immunol. 10:167–175 10.1038/ni.1690 [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Blink E.J., Light A., Kallies A., Nutt S.L., Hodgkin P.D., Tarlinton D.M. 2005. Early appearance of germinal center–derived memory B cells and plasma cells in blood after primary immunization. J. Exp. Med. 201:545–554 10.1084/jem.20042060 [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Chan T.D., Gatto D., Wood K., Camidge T., Basten A., Brink R. 2009. Antigen affinity controls rapid T-dependent antibody production by driving the expansion rather than the differentiation or extrafollicular migration of early plasmablasts. J. Immunol. 183:3139–3149 10.4049/jimmunol.0901690 [DOI] [PubMed] [Google Scholar]
  7. Chtanova T., Tangye S.G., Newton R., Frank N., Hodge M.R., Rolph M.S., Mackay C.R. 2004. T follicular helper cells express a distinctive transcriptional profile, reflecting their role as non-Th1/Th2 effector cells that provide help for B cells. J. Immunol. 173:68–78 [DOI] [PubMed] [Google Scholar]
  8. Coquet J.M., Kyparissoudis K., Pellicci D.G., Besra G., Berzins S.P., Smyth M.J., Godfrey D.I. 2007. IL-21 is produced by NKT cells and modulates NKT cell activation and cytokine production. J. Immunol. 178:2827–2834 [DOI] [PubMed] [Google Scholar]
  9. Coquet J.M., Chakravarti S., Smyth M.J., Godfrey D.I. 2008. Cutting edge: IL-21 is not essential for Th17 differentiation or experimental autoimmune encephalomyelitis. J. Immunol. 180:7097–7101 [DOI] [PubMed] [Google Scholar]
  10. Cunningham A.F., Gaspal F., Serre K., Mohr E., Henderson I.R., Scott-Tucker A., Kenny S.M., Khan M., Toellner K.M., Lane P.J., MacLennan I.C. 2007. Salmonella induces a switched antibody response without germinal centers that impedes the extracellular spread of infection. J. Immunol. 178:6200–6207 [DOI] [PubMed] [Google Scholar]
  11. Dent A.L., Shaffer A.L., Yu X., Allman D., Staudt L.M. 1997. Control of inflammation, cytokine expression, and germinal center formation by BCL-6. Science. 276:589–592 10.1126/science.276.5312.589 [DOI] [PubMed] [Google Scholar]
  12. Ettinger R., Sims G.P., Fairhurst A.M., Robbins R., da Silva Y.S., Spolski R., Leonard W.J., Lipsky P.E. 2005. IL-21 induces differentiation of human naive and memory B cells into antibody-secreting plasma cells. J. Immunol. 175:7867–7879 [DOI] [PubMed] [Google Scholar]
  13. Ettinger R., Sims G.P., Robbins R., Withers D., Fischer R.T., Grammer A.C., Kuchen S., Lipsky P.E. 2007. IL-21 and BAFF/BLyS synergize in stimulating plasma cell differentiation from a unique population of human splenic memory B cells. J. Immunol. 178:2872–2882 [DOI] [PubMed] [Google Scholar]
  14. Ettinger R., Kuchen S., Lipsky P.E. 2008. The role of IL-21 in regulating B-cell function in health and disease. Immunol. Rev. 223:60–86 10.1111/j.1600-065X.2008.00631.x [DOI] [PubMed] [Google Scholar]
  15. Fazilleau N., McHeyzer-Williams L.J., Rosen H., McHeyzer-Williams M.G. 2009. The function of follicular helper T cells is regulated by the strength of T cell antigen receptor binding. Nat. Immunol. 10:375–384 10.1038/ni.1704 [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Hess J., Ladel C., Miko D., Kaufmann S.H. 1996. Salmonella typhimurium aroA− infection in gene-targeted immunodeficient mice: major role of CD4+ TCR-alpha beta cells and IFN-gamma in bacterial clearance independent of intracellular location. J. Immunol. 156:3321–3326 [PubMed] [Google Scholar]
  17. Inamine A., Takahashi Y., Baba N., Miyake K., Tokuhisa T., Takemori T., Abe R. 2005. Two waves of memory B-cell generation in the primary immune response. Int. Immunol. 17:581–589 10.1093/intimm/dxh241 [DOI] [PubMed] [Google Scholar]
  18. Johnston R.J., Poholek A.C., Ditoro D., Yusuf I., Eto D., Barnett B., Dent A.L., Craft J., Crotty S. 2009. Bcl6 and Blimp-1 are reciprocal and antagonistic regulators of T follicular helper cell differentiation. Science. 325:1006–1010 [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Kasaian M.T., Whitters M.J., Carter L.L., Lowe L.D., Jussif J.M., Deng B., Johnson K.A., Witek J.S., Senices M., Konz R.F., et al. 2002. IL-21 limits NK cell responses and promotes antigen-specific T cell activation: a mediator of the transition from innate to adaptive immunity. Immunity. 16:559–569 [DOI] [PubMed] [Google Scholar]
  20. Korn T., Bettelli E., Gao W., Awasthi A., Jäger A., Strom T.B., Oukka M., Kuchroo V.K. 2007. IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature. 448:484–487 10.1038/nature05970 [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Kuchen S., Robbins R., Sims G.P., Sheng C., Phillips T.M., Lipsky P.E., Ettinger R. 2007. Essential role of IL-21 in B cell activation, expansion, and plasma cell generation during CD4+ T cell-B cell collaboration. J. Immunol. 179:5886–5896 [DOI] [PubMed] [Google Scholar]
  22. Linterman M.A., Rigby R.J., Wong R., Silva D., Withers D., Anderson G., Verma N.K., Brink R., Hutloff A., Goodnow C.C., Vinuesa C.G. 2009a. Roquin differentiates the specialized functions of duplicated T cell costimulatory receptor genes CD28 and ICOS. Immunity. 30:228–241 10.1016/j.immuni.2008.12.015 [DOI] [PubMed] [Google Scholar]
  23. Linterman M.A., Rigby R.J., Wong R.K., Yu D., Brink R., Cannons J.L., Schwartzberg P.L., Cook M.C., Walters G.D., Vinuesa C.G. 2009b. Follicular helper T cells are required for systemic autoimmunity. J. Exp. Med. 206:561–576 10.1084/jem.20081886 [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. MacLennan I.C., Toellner K.M., Cunningham A.F., Serre K., Sze D.M., Zúñiga E., Cook M.C., Vinuesa C.G. 2003. Extrafollicular antibody responses. Immunol. Rev. 194:8–18 10.1034/j.1600-065X.2003.00058.x [DOI] [PubMed] [Google Scholar]
  25. Malherbe L., Mark L., Fazilleau N., McHeyzer-Williams L.J., McHeyzer-Williams M.G. 2008. Vaccine adjuvants alter TCR-based selection thresholds. Immunity. 28:698–709 10.1016/j.immuni.2008.03.014 [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Nurieva R., Yang X.O., Martinez G., Zhang Y., Panopoulos A.D., Ma L., Schluns K., Tian Q., Watowich S.S., Jetten A.M., Dong C. 2007. Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature. 448:480–483 10.1038/nature05969 [DOI] [PubMed] [Google Scholar]
  27. Nurieva R.I., Chung Y., Hwang D., Yang X.O., Kang H.S., Ma L., Wang Y.H., Watowich S.S., Jetten A.M., Tian Q., Dong C. 2008. Generation of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages. Immunity. 29:138–149 10.1016/j.immuni.2008.05.009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Nurieva R.I., Chung Y., Martinez G.J., Yang X.O., Tanaka S., Matskevitch T.D., Wang Y.H., Dong C. 2009. Bcl6 mediates the development of T follicular helper cells. Science. 325:1001–1005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Odegard J.M., Marks B.R., DiPlacido L.D., Poholek A.C., Kono D.H., Dong C., Flavell R.A., Craft J. 2008. ICOS-dependent extrafollicular helper T cells elicit IgG production via IL-21 in systemic autoimmunity. J. Exp. Med. 205:2873–2886 10.1084/jem.20080840 [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Ozaki K., Spolski R., Feng C.G., Qi C.F., Cheng J., Sher A., Morse H.C., III, Liu C., Schwartzberg P.L., Leonard W.J. 2002. A critical role for IL-21 in regulating immunoglobulin production. Science. 298:1630–1634 10.1126/science.1077002 [DOI] [PubMed] [Google Scholar]
  31. Ozaki K., Spolski R., Ettinger R., Kim H.P., Wang G., Qi C.F., Hwu P., Shaffer D.J., Akilesh S., Roopenian D.C., et al. 2004. Regulation of B cell differentiation and plasma cell generation by IL-21, a novel inducer of Blimp-1 and Bcl-6. J. Immunol. 173:5361–5371 [DOI] [PubMed] [Google Scholar]
  32. Parrish-Novak J., Dillon S.R., Nelson A., Hammond A., Sprecher C., Gross J.A., Johnston J., Madden K., Xu W., West J., et al. 2000. Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature. 408:57–63 10.1038/35040504 [DOI] [PubMed] [Google Scholar]
  33. Paus D., Phan T.G., Chan T.D., Gardam S., Basten A., Brink R. 2006. Antigen recognition strength regulates the choice between extrafollicular plasma cell and germinal center B cell differentiation. J. Exp. Med. 203:1081–1091 10.1084/jem.20060087 [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Pène J., Gauchat J.F., Lécart S., Drouet E., Guglielmi P., Boulay V., Delwail A., Foster D., Lecron J.C., Yssel H. 2004. Cutting edge: IL-21 is a switch factor for the production of IgG1 and IgG3 by human B cells. J. Immunol. 172:5154–5157 [DOI] [PubMed] [Google Scholar]
  35. Phan T.G., Amesbury M., Gardam S., Crosbie J., Hasbold J., Hodgkin P.D., Basten A., Brink R. 2003. B cell receptor–independent stimuli trigger immunoglobulin (Ig) class switch recombination and production of IgG autoantibodies by anergic self-reactive B cells. J. Exp. Med. 197:845–860 10.1084/jem.20022144 [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Priatel J.J., Chui D., Hiraoka N., Simmons C.J., Richardson K.B., Page D.M., Fukuda M., Varki N.M., Marth J.D. 2000. The ST3Gal-I sialyltransferase controls CD8+ T lymphocyte homeostasis by modulating O-glycan biosynthesis. Immunity. 12:273–283 10.1016/S1074-7613(00)80180-6 [DOI] [PubMed] [Google Scholar]
  37. Randall K.L., Lambe T., Johnson A., Treanor B., Kucharska E., Domaschenz H., Whittle B., Tze L.E., Enders A., Crockford T.L., et al. 2009. Dock8 mutations cripple B cell immune synapses, germinal centers and long-lived antibody production. Nat. Immunol. 10:1283–1291 (PubMed) [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Rifaat M.A., Salem S.A., Azab M.E., Beshir S.R., Safer E.H., El-Shennawy S.F. 1981. Effect of Toxoplasma gondii on histopathology and histochemistry or reticuloendothelial system in experimental animals. Folia Parasitol. (Praha). 28:117–124 [PubMed] [Google Scholar]
  39. Rochman Y., Spolski R., Leonard W.J. 2009. New insights into the regulation of T cells by gamma(c) family cytokines. Nat. Rev. Immunol. 9:480–490 [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Schmitt N., Morita R., Bourdery L., Bentebibel S.E., Zurawski S.M., Banchereau J., Ueno H. 2009. Human dendritic cells induce the differentiation of interleukin-21-producing T follicular helper-like cells through interleukin-12. Immunity. 31:158–169 10.1016/j.immuni.2009.04.016 [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Segall T., Lindberg A.A. 1991. Salmonella dublin experimental infection in calves: protection after oral immunization with an auxotrophic aroA live vaccine. Zentralbl. Veterinarmed. B. 38:142–160 [DOI] [PubMed] [Google Scholar]
  42. Sonderegger I., Kisielow J., Meier R., King C., Kopf M. 2008. IL-21 and IL-21R are not required for development of Th17 cells and autoimmunity in vivo. Eur. J. Immunol. 38:1833–1838 10.1002/eji.200838511 [DOI] [PubMed] [Google Scholar]
  43. Spolski R., Leonard W.J. 2008. Interleukin-21: basic biology and implications for cancer and autoimmunity. Annu. Rev. Immunol. 26:57–79 10.1146/annurev.immunol.26.021607.090316 [DOI] [PubMed] [Google Scholar]
  44. Toyama H., Okada S., Hatano M., Takahashi Y., Takeda N., Ichii H., Takemori T., Kuroda Y., Tokuhisa T. 2002. Memory B cells without somatic hypermutation are generated from Bcl6-deficient B cells. Immunity. 17:329–339 10.1016/S1074-7613(02)00387-4 [DOI] [PubMed] [Google Scholar]
  45. Vogelzang A., McGuire H.M., Yu D., Sprent J., Mackay C.R., King C. 2008. A fundamental role for interleukin-21 in the generation of T follicular helper cells. Immunity. 29:127–137 10.1016/j.immuni.2008.06.001 [DOI] [PubMed] [Google Scholar]
  46. Yrlid U., Wick M.J. 2000. _Salmonella_-induced apoptosis of infected macrophages results in presentation of a bacteria-encoded antigen after uptake by bystander dendritic cells. J. Exp. Med. 191:613–624 10.1084/jem.191.4.613 [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Yu D., Rao S., Tsai L.M., Lee S.K., He Y., Sutcliffe E.L., Srivastava M., Linterman M., Zheng L., Simpson N., et al. 2009. The transcriptional repressor Bcl-6 directs T follicular helper cell lineage commitment. Immunity. 31:457–468 [DOI] [PubMed] [Google Scholar]
  48. Zhou L., Ivanov I.I., Spolski R., Min R., Shenderov K., Egawa T., Levy D.E., Leonard W.J., Littman D.R. 2007. IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat. Immunol. 8:967–974 10.1038/ni1488 [DOI] [PubMed] [Google Scholar]